GlassScriptPhysician profile
Lauren Albert
NPI 1639862154
$2,409.01
in general payments reported to CMS, 2019-2025
20 companies · $864 in 2025
The $864 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $240 · 2024: $1,305 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,319.02 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $646.18 | 2024-2025 | Remodulin, Orenitram, Remodulin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.87 | 2023-2025 | Ofev, Jascayd |
| Ani Pharmaceuticals, INC. | $357.49 | 2023-2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $305.62 | 2023-2025 | Uptravi, Opsumit |
| Astellas Pharma US INC | $211.93 | 2024-2025 | Cresemba |
| Shionogi INC | $98.59 | 2023-2024 | Fetroja |
| Mallinckrodt Hospital Products INC. | $62.54 | 2024 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $43.42 | 2024 | Livtencity |
| Veloxis Pharmaceuticals, INC. | $35.03 | 2024 | Envarsus |
| Merck Sharp & Dohme LLC | $32.95 | 2025 | Winrevair |
| Invivyd INC | $27.85 | 2025 | Pemgarda |
| Chiesi USA, INC. | $24.87 | 2023 | Bronchitol |
| Melinta Therapeutics, LLC | $24.77 | 2023 | Rezzayo, Vabomere |
| Madrigal Pharmaceuticals | $24.63 | 2025 | Rezdiffra |
| Vertex Pharmaceuticals Incorporated | $22.39 | 2023 | Trikafta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $21.28 | 2024 | Tobi Podhaler |
| Csl Behring | $20.63 | 2024 | Kcentra |
| Tactile Systems Technology INC | $19.73 | 2024 | Flexitouch Plus, Entre Plus |
| Atricure, INC. | $19.31 | 2023 | |
| Baxter Healthcare | $13.93 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.